Trusted Knowledge

The Siensmetrica platform continually updates, organizes, and ranks medical and scientific research, data, and information using unbiased, AI-backed analysis.

Trusted Knowledge

The Siensmetrica platform continually updates, organizes, and ranks medical and scientific research, data, and information using unbiased, AI-powered analysis.

Fidere Scientiae Mensurandum Esse Oportet

(To trust knowledge, it must be measured)

We’re on a mission to make it easy to find reliable, high quality, and trustworthy scientific information.

Let’s face it, when it comes to the world of healthcare research and information, we’re facing a growing crisis of trust.

Open access mandates and electronic distribution are doubling the amount of available material every eight weeks or so, but rigorous peer review takes months or years. The result is a growing chasm between the information available, and that found to be verifiably credible, high-quality research.

It’s simply not possible for a person to keep pace with all the new medical information, never mind be able to separate the reliable from the unreliable. Little wonder that there’s growing skepticism and frustration among researchers, practitioners, and other healthcare professionals.

Our goal is to solve this tremendous problem by combining advanced data science, multi-vector content analysis, and artificial intelligence to mine the mountains of research and put the most relevant, verifiable, and trustworthy information into the hands of the professionals who need it so that they can confidently make evidence-based decisions to improve healthcare outcomes.

Siensmetrica Platform Features

Search & Discovery

Discover and identify relevant, specific research topics and studies based on natural language interactions

Multi-Vector Rating

Understand the quality, impact, bias, and credibility of research based on Siensmetrica proprietary algorithms

Relationship Visualization

Explore how specific research relates to other studies through multi-modal visualizations

Who We Are

Siensmetrica was founded in 2024 by Jeff Drake and Marc Toth. Drake, a technology executive, and Toth, a healthcare industry veteran, saw that the rising ocean of published, but questionably validated research, was become a major hindrance to researchers and physicians attempting to reduce medical errors, identify new treatments, and improve patient outcomes.

After extensive research, the pair built a diverse team of experts from healthcare, clinical disease state management, data science, AI, and business development. Their mission is to develop a technology platform that could continuously analyze massive volumes of research, rate its quality based on unique metrics, and present the most relevant, reliable scientific data to healthcare professionals in a natural, easily understandable manner.

Our goal is to forge partnerships with healthcare providers and key stakeholders to advance current care standards, and contribute to the betterment of healthcare delivery through technology.

The Team

Jeff Drake, Chairman & Co-founder
A proven high-tech leader, Mr. Drake has built and led multiple successful organizations in cybersecurity, data analytics, and AI. As founder of Access360, he oversaw its acquisition by IBM and subsequently served as Director of Software Security. He also served as EVP of Business Development at Akana (acquired by Rogue Wave), and CEO and Board Member Bitvore through its 2024 acquisition by BondWave.

Marc Toth, CEO and Co-founder
A seasoned entrepreneur, Mr. Toth has built and led multiple medical device companies from startup to successful exits. He’s also an expert in raising capital and navigating mergers & acquisitions within the healthcare space. His leadership extends beyond his own ventures. He actively contributes to the industry’s future as an Independent Board Member at cutting-edge companies like FibriCheck, DEO.Care, and Nudj Health.

Our Advisory Board

Greg Bolcer, PhD
Mr. Bolcer is a computer scientist and serial entrepreneur who holds multiple patents in the computer and software technology fields. A founder and Chief Technology Officer of multiple high tech firms, the University of California Irvine awarded him the 2004 Lauds and Laurel’s Distinguished Alumnus award. He is also a member of the UCI Information & Computer Sciences Hall of Fame.

Dr. Jeffrey Curtis, MD, MPH
Dr. Curtis is a Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). He holds the Harbert-Ball Endowed Professorship in Rheumatology and leads the UAB Pharmacoepidemiology and Pharmacoeconomics Research (PEER) Unit.

Stephen Gurczynski, PhD
Mr. Gurczynski is an Assistant Research Professor of Microbiology and Immunology at the University of Michigan Medical Research Institute. His primary focus is on virology and microbiology. He has 39 publications and 8 NIH grants.

Phillip Levy, MD, MPH
Dr. Levy is a professor of emergency medicine and a leading cardiovascular disease researcher who has overseen more than 110 funded studies from various entities including the CDC, AHA, and NIH, since arriving at Wayne State in 2002. His work has been highly influential with an h-index of 52 and more than 300 published manuscripts and textbook chapters, including senior authorship on numerous guidelines, scientific statements and consensus papers.

Dr. Adam Rubenstein, MD
Dr. Rubenstein is the Director of Anesthesia Services at Henry Ford Health System. He is a clinical anesthesiologist and educator for Henry Ford Health. He is the former Service Chief for the Department of Anesthesiology, Perioperative, and Pain Medicine at Henry Ford Health Jackson.

James Salanty
Mr. Salanty has over 30 years’ experience as a biopharmaceutical professional with a number of leading pharmaceutical firms including TAP pharmaceuticals, Abbott Labs, and AbbVie. During his 10-plus years with Abbvie Vice President of Rheumatology and later its Vice President Immunology Strategy.

The Siensmetrica platform is currently available by invitation only. If you’re interested in an invitation, or you have a question or comment, please use the form below.